These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31655211)

  • 1. Transient analysis of drug delivery from a toroidal membrane: Applications for medicated vaginal rings.
    Simon L; Ospina J
    Eur J Pharm Sci; 2020 Jan; 141():105114. PubMed ID: 31655211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device.
    Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK
    J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
    Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK
    Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers.
    Dallal Bashi YH; McCoy CF; Murphy DJ; Boyd P; Spence P; Kleinbeck K; Devlin B; Malcolm RK
    Int J Pharm; 2019 Oct; 569():118574. PubMed ID: 31352053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone-releasing vaginal rings for use in postpartum contraception. I. In vitro release rates of progesterone from core-loaded rings.
    Matlin SA; Belenguer A; Hall PE
    Contraception; 1992 Apr; 45(4):329-41. PubMed ID: 1516365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled drug release from polymeric delivery devices. III: In vitro-in vivo correlation for intravaginal release of ethynodiol diacetate from silicone devices in rabbits.
    Chien YW; Mares SE; Berg J; Huber S; Lambert HJ; King KF
    J Pharm Sci; 1975 Nov; 64(11):1776-81. PubMed ID: 1195107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Information on advances in sciences and technology. Advances in contraceptive technology].
    Andrade AT
    Bol Cent Biol Reprod; 1993; 12(1):51-2. PubMed ID: 12345521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
    Clark JT; Clark MR; Shelke NB; Johnson TJ; Smith EM; Andreasen AK; Nebeker JS; Fabian J; Friend DR; Kiser PF
    PLoS One; 2014; 9(3):e88509. PubMed ID: 24599325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of research and development of vaginal contraceptive rings as a fertility control method in the female.
    Roy S; Mishell Dr
    Res Front Fertil Regul; 1983 May; 2(4):1-10. PubMed ID: 12227323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal rings for contraception: endocrine parameters.
    Olsson SE
    Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
    Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
    Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane systems: practical applications.
    Smith KL
    Methods Enzymol; 1985; 112():504-20. PubMed ID: 4046862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of the candidate antiretroviral peptides T-1249 and JNJ54310516-AFP from a rod insert vaginal ring.
    Murphy DJ; Amssoms K; Pille G; Clarke A; O'Hara M; van Roey J; Malcolm RK
    Drug Deliv Transl Res; 2016 Jun; 6(3):234-42. PubMed ID: 26787615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives, lipoproteins, and atherosclerosis.
    Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New delivery systems in contraception: vaginal rings.
    Johansson ED; Sitruk-Ware R
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S54-9. PubMed ID: 15105799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release testing methods for drug-releasing vaginal rings.
    Boyd P; Variano B; Spence P; McCoy CF; Murphy DJ; Dallal Bashi YH; Malcolm RK
    J Control Release; 2019 Nov; 313():54-69. PubMed ID: 31626862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.